| Followers | 374 |
| Posts | 5388 |
| Boards Moderated | 1 |
| Alias Born | 05/09/2013 |
Wednesday, July 27, 2016 12:42:06 PM
Ha-Ha.. Anyhow we have yet to see a final result determined on this stock movement, whether it be a multi-day trade or those who want to hold longer yet.
Once the trade has revealed itself fully for me or for anyone else (all using different time horizons perhaps), then it can be said how well it works
:)
Once the trade has revealed itself fully for me or for anyone else (all using different time horizons perhaps), then it can be said how well it works
:)
Recent ENLV News
- Enlivex to Present Phase IIa 3-month and 6-month Data of Allocetra at OARSI 2026 World Congress • GlobeNewswire Inc. • 04/23/2026 12:30:00 PM
- Form F-3 - Registration statement by foreign private issuers • Edgar (US Regulatory) • 04/21/2026 08:15:57 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/21/2026 12:32:01 PM
- Enlivex Announces Second Regulatory Approval for Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis • GlobeNewswire Inc. • 04/21/2026 12:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/08/2026 12:33:27 PM
- Ondo Global Markets Tokenizes Enlivex’s Ordinary Shares • GlobeNewswire Inc. • 04/08/2026 12:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/26/2026 12:32:01 PM
- Rain Launches an OpenClaw and AI Agent Interface Allowing Anyone To Create A Prediction Market Via A Single Prompt • GlobeNewswire Inc. • 03/26/2026 12:30:00 PM
- Enlivex shares jump after earnings as treasury gains boost results • IH Market News • 03/25/2026 03:05:33 PM
- Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)] • Edgar (US Regulatory) • 03/25/2026 12:40:17 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/25/2026 12:31:00 PM
- Enlivex Reports Full-Year 2025 Results: Profit (Net Income) of $1.23 Billion and Diluted Earnings Per Share (EPS) of $25.48 • GlobeNewswire Inc. • 03/25/2026 12:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/24/2026 12:34:59 PM
- Enlivex Announces $21 Million Debt Financing, Decentralized Prediction Markets RAIN Token-Related Updates and $20 Million Share Repurchase Program • GlobeNewswire Inc. • 03/24/2026 12:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/23/2026 12:02:14 PM
- Quality Longevity Company Enlivex Receives Investigational New Drug (IND) Clearance from the FDA for Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis • GlobeNewswire Inc. • 03/23/2026 12:00:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/20/2026 08:05:23 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 11:14:20 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/13/2026 08:17:47 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/23/2026 01:00:15 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/10/2026 01:02:52 PM
- New Listing of the RAIN Token on Kraken, the Second-Largest U.S. Cryptocurrency Exchange • GlobeNewswire Inc. • 02/10/2026 01:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/05/2026 12:50:49 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/26/2026 01:01:50 PM
